Is CPZ1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CPZ1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CPZ1 (€30.4) is trading below our estimate of fair value (€37.98)
Significantly Below Fair Value: CPZ1 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CPZ1?
Key metric: As CPZ1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for CPZ1. This is calculated by dividing CPZ1's market cap by their current
earnings.
What is CPZ1's PE Ratio?
PE Ratio
98.1x
Earnings
US$51.11m
Market Cap
US$5.02b
CPZ1 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: CPZ1 is expensive based on its Price-To-Earnings Ratio (98.1x) compared to the Global Office REITs industry average (20x).
Price to Earnings Ratio vs Fair Ratio
What is CPZ1's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
CPZ1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
98.1x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CPZ1's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst CPZ1 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€30.40
€29.27
-3.7%
16.7%
€33.25
€18.05
n/a
11
Nov ’25
€27.40
€27.85
+1.6%
16.0%
€32.30
€17.53
n/a
11
Oct ’25
€26.40
€25.77
-2.4%
14.4%
€29.70
€17.10
n/a
11
Sep ’25
€25.60
€24.79
-3.2%
13.5%
€27.99
€17.16
n/a
11
Aug ’25
€25.00
€24.72
-1.1%
12.8%
€28.68
€17.58
n/a
11
Jul ’25
€21.20
€23.21
+9.5%
10.1%
€26.73
€17.51
n/a
11
Jun ’25
€21.20
€23.21
+9.5%
10.1%
€26.73
€17.51
n/a
11
May ’25
€21.40
€23.72
+10.9%
10.5%
€27.22
€17.84
n/a
11
Apr ’25
€22.00
€23.33
+6.1%
10.5%
€26.78
€17.54
n/a
11
Mar ’25
€21.40
€23.81
+11.3%
11.5%
€27.03
€17.71
n/a
11
Feb ’25
€20.80
€23.50
+13.0%
11.5%
€26.68
€17.48
n/a
11
Jan ’25
€22.20
€22.23
+0.1%
13.0%
€26.27
€17.21
n/a
11
Dec ’24
€20.00
€21.82
+9.1%
14.2%
€26.47
€17.34
n/a
11
Nov ’24
€16.80
€23.19
+38.1%
14.9%
€27.40
€17.95
€27.40
11
Oct ’24
€19.20
€24.48
+27.5%
11.6%
€27.20
€17.82
€26.40
10
Sep ’24
€22.00
€24.76
+12.6%
7.6%
€26.85
€20.37
€25.60
8
Aug ’24
€21.80
€23.64
+8.5%
9.6%
€25.46
€19.10
€25.00
8
Jul ’24
€20.80
€23.31
+12.1%
9.0%
€25.59
€20.11
€21.20
10
Jun ’24
€17.90
€23.36
+30.5%
9.2%
€26.36
€20.00
€21.20
10
May ’24
€19.60
€23.41
+19.5%
10.5%
€26.32
€19.06
€21.40
10
Apr ’24
€19.50
€24.28
+24.5%
8.8%
€26.74
€20.28
€22.00
9
Mar ’24
€23.20
€27.15
+17.0%
12.4%
€33.58
€20.52
€21.40
9
Feb ’24
€24.60
€26.66
+8.4%
12.5%
€33.22
€20.30
€20.80
9
Jan ’24
€23.80
€27.98
+17.5%
8.3%
€33.70
€25.27
€22.20
9
Dec ’23
€24.60
€29.78
+21.1%
15.7%
€41.65
€26.15
€20.00
8
Nov ’23
€23.80
€33.02
+38.8%
15.5%
€43.52
€26.32
€16.80
8
Analyst Forecast: Target price is lower than the current share price.